bimatoprost vehicle

DRUG3 trials

Sponsors

Allergan

Conditions

AlopeciaAlopecia, AndrogeneticBaldnessGlaucomaGlaucoma, Open-AngleOcular Hypertension

Phase 2

Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01291108

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2011-04-30End: 2011-10-31Updated: 2013-11-06

A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

CompletedNCT01904721

AllerganAlopecia, Alopecia, Androgenetic, Baldness

Start: 2013-08-31End: 2015-01-31Updated: 2016-03-22

Phase 3

A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

TerminatedNCT01426113

AllerganGlaucoma

Start: 2011-09-30End: 2014-10-31Updated: 2015-10-02